nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations
|
Atre, Tanmaya |
|
|
7 |
22 |
p. 7087-7099 |
artikel |
2 |
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
|
Murthy, Hemant S. |
|
|
7 |
22 |
p. 7007-7016 |
artikel |
3 |
Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
|
Miyata, Masahiro |
|
|
7 |
22 |
p. 6936-6948 |
artikel |
4 |
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing
|
Middeldorp, Saskia |
|
|
7 |
22 |
p. 7101-7138 |
artikel |
5 |
Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody–drug conjugate
|
Gustafsson, Karin |
|
|
7 |
22 |
p. 6964-6973 |
artikel |
6 |
Clearing the way for new therapies in clonal hematopoiesis
|
Ling, Victoria Y. |
|
|
7 |
22 |
p. 7151-7152 |
artikel |
7 |
Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation
|
Landy, Emily |
|
|
7 |
22 |
p. 6949-6963 |
artikel |
8 |
DeFilipp Z, Kim HT, Yang Z, et al. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials. Blood Adv. 2022;6(24):6263-6270.
|
|
|
|
7 |
22 |
p. 7006 |
artikel |
9 |
De novo hematopoiesis from the fetal lung
|
Yeung, Anthony K. |
|
|
7 |
22 |
p. 6898-6912 |
artikel |
10 |
DuMontier C, La J, Bihn J, et al. More intensive therapy has a better effect for frail parents with multiple myeloma. Blood Adv. 2023;7(20):6275-6284.
|
|
|
|
7 |
22 |
p. 7100 |
artikel |
11 |
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
|
Blumenberg, Viktoria |
|
|
7 |
22 |
p. 6844-6849 |
artikel |
12 |
Editorial Board
|
|
|
|
7 |
22 |
p. i |
artikel |
13 |
Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis
|
Liang, Raymond |
|
|
7 |
22 |
p. 6873-6885 |
artikel |
14 |
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
|
Liang, Emily C. |
|
|
7 |
22 |
p. 6990-7005 |
artikel |
15 |
Front Matter
|
|
|
|
7 |
22 |
p. ii |
artikel |
16 |
Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A
|
Hiramoto, Takafumi |
|
|
7 |
22 |
p. 7017-7027 |
artikel |
17 |
HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM
|
Chang, Hae Yeun |
|
|
7 |
22 |
p. 6859-6872 |
artikel |
18 |
Ibrutinib in the treatment of relapsed FL and MZL?
|
Schmitz, Norbert |
|
|
7 |
22 |
p. 7139-7140 |
artikel |
19 |
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
|
Annunzio, Kaitlin |
|
|
7 |
22 |
p. 6839-6843 |
artikel |
20 |
Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis
|
Adrianzen-Herrera, Diego |
|
|
7 |
22 |
p. 6913-6922 |
artikel |
21 |
Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma
|
Bønløkke, Søren Thorgaard |
|
|
7 |
22 |
p. 7056-7066 |
artikel |
22 |
Intensive hydroxyurea dosing in very young children with sickle cell anemia
|
Wang, Winfred C. |
|
|
7 |
22 |
p. 6931-6935 |
artikel |
23 |
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27
|
Oerlemans, Simone |
|
|
7 |
22 |
p. 7045-7055 |
artikel |
24 |
Intrapatient competition of VEXAS syndrome and CML clones
|
Djerbi, Nadia |
|
|
7 |
22 |
p. 6815-6818 |
artikel |
25 |
Natural history and variability in albuminuria in pediatric and murine sickle cell anemia
|
Kasztan, Malgorzata |
|
|
7 |
22 |
p. 6850-6858 |
artikel |
26 |
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
|
Nastoupil, Loretta J. |
|
|
7 |
22 |
p. 7141-7150 |
artikel |
27 |
Progenitor-like cell type of an MLL-EDC4 fusion in acute myeloid leukemia
|
Schuster, Linda C. |
|
|
7 |
22 |
p. 7079-7083 |
artikel |
28 |
Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL
|
Tam, Constantine |
|
|
7 |
22 |
p. 6819-6828 |
artikel |
29 |
Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries
|
Klein, Lauren Jane |
|
|
7 |
22 |
p. 6923-6930 |
artikel |
30 |
Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report
|
Balas, Nora |
|
|
7 |
22 |
p. 7028-7044 |
artikel |
31 |
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
|
Opat, Stephen |
|
|
7 |
22 |
p. 6801-6811 |
artikel |
32 |
Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603–5607.
|
|
|
|
7 |
22 |
p. 6829 |
artikel |
33 |
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union
|
Valentini, Caterina Giovanna |
|
|
7 |
22 |
p. 7084-7086 |
artikel |
34 |
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia
|
Catto, Luiz Fernando B. |
|
|
7 |
22 |
p. 7067-7078 |
artikel |
35 |
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
|
Taylor, Mallory R. |
|
|
7 |
22 |
p. 6830-6838 |
artikel |
36 |
Vitamin C and D supplementation in acute myeloid leukemia
|
Mouchel, Pierre Luc |
|
|
7 |
22 |
p. 6886-6897 |
artikel |
37 |
VWF–ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion
|
Fogarty, Helen |
|
|
7 |
22 |
p. 6974-6989 |
artikel |
38 |
World Coalition on SCD launches, sparking global focus on SCD diagnosis and care
|
Zapfel, Andrew |
|
|
7 |
22 |
p. 6812-6814 |
artikel |